✦ LIBER ✦

Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV)

✍ Scribed by Delvyn C. Case Jr.; Charles W. Young; Andburton J. Lee III

Publisher: John Wiley and Sons
Year: 1977
Tongue: English
Weight: 346 KB
Volume: 39
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197704)39:4<1382::aid-cncr2820390405>3.0.co;2-f

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of MOPP-refractory Hodgkin-s d

Treatment of MOPP-refractory Hodgkin-s disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine

✍ Lawrence H. Einhorn; Stephen D. Williams; Eugene E. Stevens; William H. Bond; Li 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Eighteen patients with advanced Hodgkin's disease, refractory to combination chemotherapy with nitrogen mustard, vincristine, prednisone, and procarbazine (MOPP), were treated with vinblastine, doxorubicin (Adriamycin), bleomycin, CCNU, and dacarbazine (DTIC) (VABCD). Fifteen patients had Stage IV d

Treatment of advanced Hodgkin's disease

Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy

✍ John G. Krikorian; Carol S. Portlock; Dr. Saul A. Rosenberg 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 2 views

twenty-seven patients with advanced Hodgkin's disease who failed MOPP (nitrogen mustard, vincristine, procarbazine and prednisone) were treated with adriamycin, bleomycin, vinblastine, and imidazole carboxamide, (ABVD). Complete response (CR) was achieved in 22% of patients and partial response was

Treatment of Hodgkin's disease in childr

Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy

✍ van den Berg, Henk; Stuve, Wouter; Behrendt, Henk 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

Since the introduction of mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) chemotherapy, children with Hodgkin's disease (HD) have been treated with chemotherapy alone. The occurrence of side effects related to irradiation (especially secondary solid tumors) is less likely to occur.

ACUTE MYELOID LEUKEMIA FOLLOWING THERAPY

ACUTE MYELOID LEUKEMIA FOLLOWING THERAPY OF HODGKIN'S DISEASE WITH RADIOTHERAPY AND ABVD (DOXORUBICIN, BLEOMYCIN, VINBLASTINE, AND DACARBAZINE)

✍ J. H. LIPTON; M. GOSPODAROWICZ; S. REINGOLD 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 1 views

A 26-year-old man developed myelodysplasia rapidly progressing to acute myelomonocytic leukemia 3 years after receiving three cycles of ABVD chemotherapy and upper mantle and upper abdomen radiotherapy for stage IA Hodgkin's disease. This represents the fourth such case reported. The risk of seconda

Hybrid chemotherapy consisting of cyclop

Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced hodgkin disease

✍ Silvia Montoto; Mireia Camós; Armando López-Guillermo; Francesc Bosch; Francisco 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## BACKGROUND. Combination chemotherapy, including hybrid regimens, is the standard treatment for patients with advanced Hodgkin disease (HD). Although a prolonged complete response (CR) is achieved in up to 70 -80% of patients, long term complications, such as secondary leukemia, are of concern. C